Literature DB >> 11207170

Idiopathic thrombocytopenic purpura and MMR vaccine.

E Miller1, P Waight, C P Farrington, N Andrews, J Stowe, B Taylor.   

Abstract

A CAUSAL ASSOCIATION BETWEEN MEASLES: mumps-rubella (MMR) vaccine and idiopathic thrombocytopenic purpura (ITP) was confirmed using immunisation/hospital admission record linkage. The absolute risk within six weeks of immunisation was 1 in 22 300 doses, with two of every three cases occurring in the six week post-immunisation period being caused by MMR. Children with ITP before MMR had no vaccine associated recurrences.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11207170      PMCID： PMC1718684          DOI： 10.1136/adc.84.3.227

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  9 in total

1.  COVER (cover of vaccination evaluated rapidly): description of the England and Wales scheme.

Authors:  N T Begg; O N Gill; J M White
Journal:  Public Health       Date:  1989-03       Impact factor: 2.427

2.  Relative incidence estimation from case series for vaccine safety evaluation.

Authors:  C P Farrington
Journal:  Biometrics       Date:  1995-03       Impact factor: 2.571

3.  Thrombocytopenic purpura after a combined vaccine against morbilli, parotitis and rubella.

Authors:  J Neiderud
Journal:  Acta Paediatr Scand       Date:  1983-07

4.  Recurrent thrombocytopenic purpura after repeated measles-mumps-rubella vaccination.

Authors:  V Vlacha; E N Forman; D Miron; G Peter
Journal:  Pediatrics       Date:  1996-05       Impact factor: 7.124

5.  Effect of live measles vaccine on the platelet count.

Authors:  F A Oski; J L Naiman
Journal:  N Engl J Med       Date:  1966-08-18       Impact factor: 91.245

6.  Acute thrombocytopenic purpura following measles, mumps and rubella vaccination. A report on 23 patients.

Authors:  U Nieminen; H Peltola; M T Syrjälä; A Mäkipernaa; R Kekomäki
Journal:  Acta Paediatr       Date:  1993-03       Impact factor: 2.299

7.  A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines.

Authors:  P Farrington; S Pugh; A Colville; A Flower; J Nash; P Morgan-Capner; M Rush; E Miller
Journal:  Lancet       Date:  1995-03-04       Impact factor: 79.321

8.  Thrombocytopenia in childhood: an evaluation of 433 patients.

Authors:  J Cohn
Journal:  Scand J Haematol       Date:  1976-03

9.  Swedish experience of two dose vaccination programme aiming at eliminating measles, mumps, and rubella.

Authors:  M Böttiger; B Christenson; V Romanus; J Taranger; A Strandell
Journal:  Br Med J (Clin Res Ed)       Date:  1987-11-14
  9 in total
  38 in total

1.  MMR vaccine and idiopathic thrombocytopaenic purpura.

Authors:  Corri Black; James A Kaye; Hershel Jick
Journal:  Br J Clin Pharmacol       Date:  2003-01       Impact factor: 4.335

2.  Temporal data mining for adverse events following immunization in nationwide Danish healthcare databases.

Authors:  Henrik Svanström; Torbjörn Callréus; Anders Hviid
Journal:  Drug Saf       Date:  2010-11-01       Impact factor: 5.606

Review 3.  When should vaccination be contraindicated in children?

Authors:  Laura Lane; Arlene Reynolds; Mary Ramsay
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

4.  Do childhood vaccines cause thrombocytopenia?

Authors:  Laura J Sauvé; David Scheifele
Journal:  Paediatr Child Health       Date:  2009-01       Impact factor: 2.253

Review 5.  Pathophysiology and therapeutic options in primary immune thrombocytopenia.

Authors:  Roberto Stasi
Journal:  Blood Transfus       Date:  2010-11-26       Impact factor: 3.443

Review 6.  Immune thrombocytopenic purpura (ITP) associated with vaccinations: a review of reported cases.

Authors:  Carlo Perricone; Fulvia Ceccarelli; Gideon Nesher; Elisabetta Borella; Qasim Odeh; Fabrizio Conti; Yehuda Shoenfeld; Guido Valesini
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

Review 7.  Vaccine administration and the development of immune thrombocytopenic purpura in children.

Authors:  Valerio Cecinati; Nicola Principi; Letizia Brescia; Paola Giordano; Susanna Esposito
Journal:  Hum Vaccin Immunother       Date:  2013-01-16       Impact factor: 3.452

8.  Updated international consensus report on the investigation and management of primary immune thrombocytopenia.

Authors:  Drew Provan; Donald M Arnold; James B Bussel; Beng H Chong; Nichola Cooper; Terry Gernsheimer; Waleed Ghanima; Bertrand Godeau; Tomás José González-López; John Grainger; Ming Hou; Caroline Kruse; Vickie McDonald; Marc Michel; Adrian C Newland; Sue Pavord; Francesco Rodeghiero; Marie Scully; Yoshiaki Tomiyama; Raymond S Wong; Francesco Zaja; David J Kuter
Journal:  Blood Adv       Date:  2019-11-26

9.  Association between drug and vaccine use and acute immune thrombocytopenia in childhood: a case-control study in Italy.

Authors:  Federica Bertuola; Carla Morando; Francesca Menniti-Ippolito; Roberto Da Cas; Annalisa Capuano; Giorgio Perilongo; Liviana Da Dalt
Journal:  Drug Saf       Date:  2010-01-01       Impact factor: 5.606

10.  Investigation of daytime wetting: when is spinal cord imaging indicated?

Authors:  E Wraige; M Borzyskowski
Journal:  Arch Dis Child       Date:  2002-08       Impact factor: 3.791
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.